We work closely with patient associations, as our goal is to improve the health of Canadians living with diseases. AbbVie is fully committed to upholding the highest ethical standards regarding patient association funding, and our current process meets these standards.
We also follow the Innovative Medicine Canada (IMC) Code of ethical practices. To learn more, we encourage you to visit section 3.3 - Guidelines for transparency in funding of patient and advocacy groups and patient associations (including annex A) from the 2022 Code of Ethical Practices document listed on the Innovative Medicines Canada Web site.
Some patient associations that receive support from AbbVie include: